Polymyalgia rheumatica: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
mNo edit summary |
||
| Line 22: | Line 22: | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:00, 5 October 2024
Polymyalgia rheumatica, also known as Forestier-Certonciny syndrome and Rhizomelic pseudopolyarthritis, is a disorder in the elderly characterized by proximal joint and muscle pain, high erythrocyte sedimentation rate, and a self-limiting course. Pain is usually accompanied by evidence of an inflammatory reaction. Women are affected twice as commonly as men and Caucasians more frequently than other groups. The condition is frequently associated with giant cell arteritis and some theories pose the possibility that the two diseases arise from a single etiology or even that they are the same entity.[1] ,
Differential diagnosis
Alternatives to consider include:[2]
- Rheumatoid arthritis
- Depression
- Hypothyroidism
- Polymyositis and dermatomyositis
- Systemic lupus erythematosus
- Temporal arteritis
- Fibromyalgia
- Osteoarthritis
- Occult infection
- Myopathy
Treatment
Treatment options have been reviewed.[3]
References
- ↑ Anonymous (2024), Polymyalgia rheumatica (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Geofrey Nochimson (4 December 2009), "Polymyalgia Rheumatica: Differential Diagnoses & Workup", eMedicine
- ↑ Hernández-Rodríguez J, Cid MC, López-Soto A, Espigol-Frigolé G, Bosch X (2009). "Treatment of polymyalgia rheumatica: a systematic review.". Arch Intern Med 169 (20): 1839-50. DOI:10.1001/archinternmed.2009.352. PMID 19901135. Research Blogging.